ONCrg Pipeline Strategies delivers comprehensive, up-to-date oncology pipeline coverage

ONCrg Pipeline Strategies reports are comprehensive collections of profiles for products in Phase I/II development and beyond updated on a quarterly basis ensuring that our clients have the most current and complete view of the rapidly changing landscape in oncology therapeutic agent development.

We’ve got you covered!

ONCrg Pipeline Strategies reports are presented in two formats:

1) An executive-level, presentation-friendly PowerPoint report that provides key information for each product on a single slide including MOA, SWOT analysis, clinical trial timelines and recent milestones.

2) A highly granular, text-oriented report that also includes clinical trial profiles for all relevant and ongoing trials including available results and statistical analyses.

Analytics prepared by our oncology-area experts shape the profiles into functional resources for assessing development in various contexts including specific disease stages, tumor genotypes and targeted pathways. Our ONCrg Advisory service is also available to tailor further pipeline analytics to your non-proprietary inquiries.

When you receive the ONCrg Pipeline Strategies reports each quarter you can be assured that you have the most up-to-date, inclusive and accurate competitive pipeline information for your oncology area of interest.

“Thank you very much. I must say I am very impressed with the thoroughness and quality of your report.”
Medical Science Liaison